Literature DB >> 2615430

Inhibitory activity of Jatropha multifida latex on classical complement pathway activity in human serum mediated by a calcium-binding proanthocyanidin.

S Kosasi1, L A Hart, H van Dijk, R P Labadie.   

Abstract

This study isolates and characterizes the anti-complement constituent(s) present in the latex of Jatropha multifida, in an attempt to explain the traditional application of the latex in the treatment of infected wounds. Guided by the inhibition of classical pathway (CP) complement activity in human serum, a polymer was isolated which could be characterized as a proanthocyanidin. The polymer inhibits CP activation of the complement cascade, while alternative pathway (AP) activation is relatively insensitive to the polymer. This is due to the selective depletion of Ca2+, but not Mg2+, from the incubation medium.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2615430     DOI: 10.1016/0378-8741(89)90080-9

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  4 in total

1.  In vitro remineralization effects of grape seed extract on artificial root caries.

Authors:  Qian Xie; Ana Karina Bedran-Russo; Christine D Wu
Journal:  J Dent       Date:  2008-09-25       Impact factor: 4.379

2.  The wound healing action of a cream latex formulation of Jatropha gaumeri Greenm. in a pre-clinical model.

Authors:  Floribeth León; Vianey Hernandez-Zapata; Manuel Chan Bacab; Guadalupe Maldonado; Juan Arana Lezama; Victor Monteon
Journal:  Vet World       Date:  2020-11-25

Review 3.  Complement activation and inhibition in wound healing.

Authors:  Gwendolyn Cazander; Gerrolt N Jukema; Peter H Nibbering
Journal:  Clin Dev Immunol       Date:  2012-12-30

4.  Comparative evaluation of grape seed and cranberry extracts in preventing enamel erosion: An optical emission spectrometric analysis.

Authors:  Mahalakshmi Nandakumar; Iffat Nasim
Journal:  J Conserv Dent       Date:  2018 Sep-Oct
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.